UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

De‐escalation of five‐year adjuvant endocrine therapy in patients with estrogen receptor‐low positive (immunohistochemistry staining 1%‐10%) breast cancer: Propensity‐matched analysis from a prospectively maintained cohort

Cancer, 2022-05, Vol.128 (9), p.1748-1756

2022

Volltextzugriff (PDF)

Breast Cancer Vaccines: Disappointing or Promising?

Frontiers in immunology, 2022-01, Vol.13, p.828386-828386

2022

Volltextzugriff (PDF)

Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis

Nature communications, 2022-02, Vol.13 (1), p.791-791, Article 791

2022

Volltextzugriff (PDF)

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer

Clinical cancer research, 2019-08, Vol.25 (16), p.5002-5014

2019

Volltextzugriff (PDF)

Breast cancer in China

The lancet oncology, 2014-06, Vol.15 (7), p.e279-e289

2014

Volltextzugriff (PDF)

Combined Single‐Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination

Advanced science, 2023-02, Vol.10 (6), p.e2205395-n/a

2023

Volltextzugriff (PDF)

Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions

Cancer communications (London, England), 2023-03, Vol.43 (3), p.297-337

2023

Volltextzugriff (PDF)

Effect of Ki-67 Expression Levels and Histological Grade on Breast Cancer Early Relapse in Patients with Different Immunohistochemical-based Subtypes

Scientific reports, 2020-05, Vol.10 (1), p.7648, Article 7648

2020

Volltextzugriff (PDF)

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Nature communications, 2020-11, Vol.11 (1), p.5679-5679, Article 5679

2020

Volltextzugriff (PDF)

The spectrum of BRCA mutations and characteristics of BRCA‐associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next‐generation sequencing

International journal of cancer, 2017-07, Vol.141 (1), p.129-142

2017

Volltextzugriff (PDF)

Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer

JNCI : Journal of the National Cancer Institute, 2021-07, Vol.113 (7), p.884-892

2021

Volltextzugriff (PDF)

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

Breast cancer research : BCR, 2016-03, Vol.18 (1), p.33-33, Article 33

2016

Volltextzugriff (PDF)

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Clinical cancer research, 2016-10, Vol.22 (19), p.4859-4869

2016

Volltextzugriff (PDF)

Cyclophosphamide-Free Adjuvant Chemotherapy for Ovarian Protection in Young Women With Breast Cancer: A Randomized Phase 3 Trial

JNCI : Journal of the National Cancer Institute, 2021-10, Vol.113 (10), p.1352-1359

2021

Volltextzugriff (PDF)

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial

Cancer, 2019-07, Vol.125 (13), p.2185-2193

2019

Volltextzugriff (PDF)

Determining the Optimal (Neo)Adjuvant Regimen for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Regarding Survival Outcome: A Network Meta-Analysis

Frontiers in immunology, 2022-06, Vol.13, p.919369-919369

2022

Volltextzugriff (PDF)

Phase separations in oncogenesis, tumor progressions and metastasis: a glance from hallmarks of cancer

Journal of hematology and oncology, 2023-12, Vol.16 (1), p.123-123, Article 123

2023

Volltextzugriff (PDF)

Estrogen receptor‐low breast cancer: Biology chaos and treatment paradox

Cancer communications (London, England), 2021-10, Vol.41 (10), p.968-980

2021

Volltextzugriff (PDF)

Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis

BMC cancer, 2013-05, Vol.13 (1), p.240-240, Article 240

2013

Volltextzugriff (PDF)

Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis

Scientific reports, 2019-01, Vol.9 (1), p.286-286, Article 286

2019

Volltextzugriff (PDF)

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

The lancet oncology, 2024-02, Vol.25 (2), p.184-197

2024

Volltextzugriff (PDF)

The Residual Tumor Autophagy Marker LC3B Serves as a Prognostic Marker in Local Advanced Breast Cancer after Neoadjuvant Chemotherapy

Clinical cancer research, 2013-12, Vol.19 (24), p.6853-6862

2013

Volltextzugriff (PDF)

A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer

Cancer research (Chicago, Ill.), 2018-06, Vol.78 (11), p.3087-3097

2018

Volltextzugriff (PDF)

GATA3 mutations define a unique subtype of luminal‐like breast cancer with improved survival

Cancer, 2014-05, Vol.120 (9), p.1329-1337

2014

Volltextzugriff (PDF)

1 – 25 von 329

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(297)

Publikationsform

Sprache

Englisch
(304)
Chinesisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Breast Cancer Research And Treatment
(29)
Plos One
(19)
Cancer Research
(15)
Oncotarget
(7)
Clinical Cancer Research
(6)
Annals Of Surgical Oncology
(5)
Applied Mechanics And Materials
(5)
Ssrn Electronic Journal
(5)
Bmc Cancer
(4)
Cancer
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

De‐escalation of five‐year adjuvant endocrine therapy in patients with estrogen receptor‐low positive (immunohistochemistry staining 1%‐10%) breast cancer: Propensity‐matched analysis from a prospectively maintained cohort

Breast Cancer Vaccines: Disappointing or Promising?

Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies

Breast cancer in China

Combined Single‐Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination

Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions

Effect of Ki-67 Expression Levels and Histological Grade on Breast Cancer Early Relapse in Patients with Different Immunohistochemical-based Subtypes

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

The spectrum of BRCA mutations and characteristics of BRCA‐associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next‐generation sequencing

Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Cyclophosphamide-Free Adjuvant Chemotherapy for Ovarian Protection in Young Women With Breast Cancer: A Randomized Phase 3 Trial

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial

Determining the Optimal (Neo)Adjuvant Regimen for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Regarding Survival Outcome: A Network Meta-Analysis

Phase separations in oncogenesis, tumor progressions and metastasis: a glance from hallmarks of cancer

Estrogen receptor‐low breast cancer: Biology chaos and treatment paradox

Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis

Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

The Residual Tumor Autophagy Marker LC3B Serves as a Prognostic Marker in Local Advanced Breast Cancer after Neoadjuvant Chemotherapy

A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer

GATA3 mutations define a unique subtype of luminal‐like breast cancer with improved survival

Suchergebnisse filtern